Francesco Ardesi, Paolo Delvino, Marco Vanetti, Martina Zappa, Patrizia Pignatti, Rosella Centis, Veronica Capuano, Alessandro Maria Marra, Francesco Bini, Stefania Gallo, Giulia Franzini, Daniela Gallo, Eliana Piantanida, Nicola Sverzellati, Antonio Spanevello, Dina Visca
{"title":"Addressing unmet needs in uncontrolled asthma through a specialized severe asthma center<b />.","authors":"Francesco Ardesi, Paolo Delvino, Marco Vanetti, Martina Zappa, Patrizia Pignatti, Rosella Centis, Veronica Capuano, Alessandro Maria Marra, Francesco Bini, Stefania Gallo, Giulia Franzini, Daniela Gallo, Eliana Piantanida, Nicola Sverzellati, Antonio Spanevello, Dina Visca","doi":"10.4081/monaldi.2026.3908","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3908","url":null,"abstract":"<p><p>Severe asthma represents a clinically challenging proportion of the asthma population, characterized by persistent symptoms, frequent exacerbations, and a higher healthcare burden. To address the complexity of uncontrolled disease, specialized severe asthma clinics have emerged as key models for delivering precision medicine through multidimensional assessment and tailored interventions. This paper describes the organization, clinical approach, and multidisciplinary framework of a tertiary Severe Asthma Centre established in Northern Italy in 2017. The center integrates prioritized outpatient access with a structured day-hospital program (Complex Outpatient Macro Activity, MAC), enabling accelerated diagnostic work-up, comprehensive phenotyping/endotyping, and repeated educational interventions. Central elements include confirmation of diagnosis, assessment of type 2 inflammatory biomarkers (FeNO, IgE, blood and sputum eosinophils), evaluation of airway inflammation, and systematic identification of pulmonary and extrapulmonary treatable traits. A broad multidisciplinary network supports the management of comorbidities such as allergic rhinitis, chronic rhinosinusitis, hypereosinophilic disorders, allergic bronchopulmonary aspergillosis, metabolic and endocrine complications, gastroesophageal reflux disease, and vocal cord dysfunction. Pulmonary rehabilitation is integrated as an adjunctive intervention, particularly for patients with severe disease. Our severe asthma clinic implements precision medicine and the treatable traits approach in clinical practice to optimize outcomes, rationalize biologic therapy use, and reduce glucocorticoid exposure. Future perspectives include expansion toward a \"united airways disease\" clinic, integrating upper and lower airway management to further improve care for complex inflammatory airway diseases.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801304","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Determinants of delayed pulmonary tuberculosis diagnosis in a rural district of Pakistan.","authors":"Amin Ur Rahman, Zia Qamar, Afnan Fayaz, Bushra Arif, Ihtisham Habib, Wareesha Naeem Aurakzai","doi":"10.4081/monaldi.2026.3782","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3782","url":null,"abstract":"<p><p>Tuberculosis (TB) caused by acid-fast bacilli is one of the leading causes of morbidity and mortality in developing countries. Pakistan has the world's fifth-largest prevalence of TB, with 276/100,000 cases in prevalence and a mortality of 34/100,000. Delayed diagnosis, disruptions in treatment continuity and a lack of awareness are the key issues leading to multidrug-resistant TB. The current study aimed to find out the determinants of delayed pulmonary TB in a rural district of Khyber Pakhtunkhwa Province, Pakistan. The cross-sectional study was conducted in six TB control program centers designated by the National TB Control Program from March to December 2024. Data were collected from 250 eligible patients, and after removal of incomplete questionnaires, the data of 229 patients were analyzed. The study was approved by the district TB officer, and participants' consent was obtained before data collection. A delay of >21 days was considered the cutoff point for delayed TB diagnosis. Among 229 patients, 51.1% were male and 48.9% female participants, with a mean age of 33.31±21.32 years. The mean diagnostic delay was 23.66±14.94 days. Descriptive analysis of data showed 52% of delayed TB diagnosis cases; 92.2% of the studied patients were from rural areas, in which 80% of delayed TB diagnosis cases were reported. Male gender [odds ratio (OR)=2.31], getting treatment from public hospitals (OR=4.13), age group 31-45 years (OR=3.10), presence of acute extrapulmonary symptoms of cough, fever, and weight loss (OR=2.84), perception that the symptoms will be relieved by oneself (OR=9.99), economic constraints (OR=6.58), and perception of the poor quality of healthcare services at hospitals (OR=7.32) were found to be significant factors of delayed TB diagnosis. Primary school- (OR=0.20), college- or university-level education (OR=0.42) and high-income groups (OR=0.39) were significant protective factors against delayed TB diagnosis. Marital status, occupation, residence, comorbidities, distance from healthcare facility, previous exposure to TB patients, fever, weight loss, chronic cough, hemoptysis, fear of diagnosis, fear of social isolation, and bad experience of the healthcare staff behavior were found to be non-significant factors for delayed TB diagnosis. The study only focused on delayed diagnosis and did not report healthcare system-related or total delay in tuberculosis management. The study affirmed the significant impact of patient perceptions and socioeconomic status on delayed TB diagnosis.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-08-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801312","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Exploring the periodontal health status and level of matrix metalloproteinases in patients with interstitial lung disease: a case control study.","authors":"Prerna S Hirkane, Umesh Pratap Verma, Ajay Kumar Verma, Pavitra Rastogi, Ashutosh Shrivastava, Anjani Kumar Pathak","doi":"10.4081/monaldi.2026.3753","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3753","url":null,"abstract":"<p><p>Periodontitis has been linked to several respiratory diseases such as chronic obstructive pulmonary disease, asthma, and lung cancer; however, the role of periodontal health status and matrix metalloproteinases (MMPs) in interstitial lung diseases (ILDs) remains largely unexplored. The present study aimed to investigate periodontal health and evaluate serum and salivary levels of MMP-7, MMP-8, and tissue inhibitor of metalloproteinase-1 (TIMP-1) in patients with ILDs. A total of 75 individuals were included and divided equally into three groups: healthy controls, patients with chronic periodontitis, and patients with ILDs. Demographic factors such as age, gender, and socioeconomic status were recorded, along with clinical parameters including plaque index, gingival index, probing pocket depth, and clinical attachment level. The findings revealed that levels of MMP-7 and MMP-8 were significantly elevated in both the periodontitis and ILD groups compared to healthy controls, while TIMP-1 did not show notable variation among groups. Clinical periodontal parameters were also higher in patients with ILDs as well as those with chronic periodontitis. These results suggest a possible link between ILD and chronic periodontitis, both from clinical and biochemical perspectives. The study provides pioneering evidence in the emerging field of oral-systemic research, emphasizing the need for further investigations with larger sample sizes and interventional designs to strengthen the evidence base and explore possible genetic associations underlying this relationship.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801325","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Hypertension cost in primary health care facilities in Morocco: a cost-of-illness study.","authors":"Soumaya Benmaamar, Moncef Maiouak, Ibtissam El Harch, Angela Christie Filankembo Kava, Passy Conde, Khalid Khilou, Noura Qarmiche, Samira El Fakir, Mohamed Berraho, Nabil Tachfouti","doi":"10.4081/monaldi.2026.3816","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3816","url":null,"abstract":"<p><p>Hypertension in low- and middle-income countries such as Morocco has an economic importance due to its high prevalence and cost. The aim of this study is to estimate direct health costs (DHC) for hypertension patients followed in primary health care facilities in Morocco. A cost of illness prevalence-based study was carried out on hypertension patients followed in public primary health care facilities in Fez. Data were collected using a questionnaire, including sociodemographic and clinical data and healthcare resources utilization: medical tests, medications, and medical visits. DHC was estimated using a bottom-up approach method from a societal perspective and a one-year time horizon. Official prices published by the national agency for health insurance were adopted as unit costs. Cost was compared to annual household income for calculating the catastrophic cost. Cost is defined as catastrophic if it exceeds 10% of annual household income. We included 146 patients. The mean age was 60.7±11.1 years; 70.5% were men. More than half (54.2%) of participants had uncontrolled hypertension. The direct medical cost was estimated at 368.8±120.8 United States dollars per patient. Costs of medical tests and drugs represented, respectively, 58.6% and 30.5% of total direct cost. The incidence of catastrophic cost was 76.8%. Hypertensive patients incur substantial direct costs. High rates of catastrophic costs illustrate the urgency of improving financial risk protection for these patients and strengthening primary care to ensure the affordability of hypertension care.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801307","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Marco Contoli, Marco Biagini, Paolo Onorati, Giovanni Sotgiu, Roberto Trevisan, Walter Castellani
{"title":"The Italian Community-based Pulmonology Manifesto: a national survey exploring the current state, critical issues, and perspectives for a national reference model.","authors":"Marco Contoli, Marco Biagini, Paolo Onorati, Giovanni Sotgiu, Roberto Trevisan, Walter Castellani","doi":"10.4081/monaldi.2026.4135","DOIUrl":"https://doi.org/10.4081/monaldi.2026.4135","url":null,"abstract":"<p><p>In Italy, demographic aging, increasing multimorbidity, and the growing burden of chronic respiratory conditions have highlighted the need for a reorganization of community-based respiratory services, as outlined by the Italian Ministerial Decree 77/2022, which promotes integrated, proximity-based models of care. Community-based pulmonology care represents a potentially pivotal component of healthcare systems for the management of chronic and complex respiratory diseases. A national, anonymous, web-based survey was conducted among Italian pulmonologists working in territorial and community healthcare settings. The questionnaire explored organizational structures, clinical and diagnostic activities, availability of technological resources, care pathways, continuity of care, and integration with hospital services. A total of 168 valid questionnaires were collected and analyzed using descriptive methods. The survey revealed substantial heterogeneity across regions and healthcare organizations in terms of structural models, availability of diagnostic and interventional procedures, multidisciplinary teams, and access to telemedicine solutions. While several community services provide advanced outpatient and home-based respiratory care, significant gaps persist in standardized care pathways, timely access to functional respiratory diagnostics, and structured follow-up of chronic patients. Limitations in direct access to hospitalization pathways further contribute to fragmentation of care and potentially optimizable use of emergency medical services. This survey provides an initial, comprehensive overview of the current state of community-based pulmonology in Italy. The collected data represent a foundational framework for further in-depth analyses aimed at defining shared minimum standards, strengthening hospital-community integration, and supporting the development of a more equitable, efficient, and patient-centered model of respiratory care.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-27","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148801333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Krishna Priya C V, Lakshmi Ramamoorthy, Pratap Upadhya, H T Lalthanthuami
{"title":"Impact of self-management interventions initiated during hospitalization on inhaler adherence and functional outcomes in patients with acute exacerbation of chronic obstructive pulmonary disease: a randomized controlled trial.","authors":"Krishna Priya C V, Lakshmi Ramamoorthy, Pratap Upadhya, H T Lalthanthuami","doi":"10.4081/monaldi.2026.3695","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3695","url":null,"abstract":"<p><p>Chronic obstructive pulmonary disease (COPD) remains a leading global health burden, with acute exacerbations accelerating functional decline and impairing quality of life. Reduced inhaler adherence is a well-recognized contributor to exacerbations and poorer outcomes in COPD. While self-management interventions are well established in stable COPD, their initiation during acute exacerbations has been inadequately explored. This randomized controlled trial, conducted in a South Indian tertiary hospital between July 2024 and May 2025, evaluated the effectiveness of a structured self-management program initiated during hospitalization for acute exacerbation of COPD. The intervention included individualized counseling, family engagement, structured telephonic follow-ups (weekly for 3 months, then monthly for 3 months), and scheduled outpatient reviews, while controls received standard care. Primary outcomes were inhaler adherence assessed by the Test of Adherence to Inhalers, health-related quality of life (HRQoL) measured with the St. George's Respiratory Questionnaire (SGRQ), and functional capacity assessed by the six-minute walk test. At six months, good inhaler adherence was observed in 66.7% of the intervention group compared to 10% of controls (p<0.001). The mean between-group difference in six-minute walk distance at six months was 92.8 meters [95% confidence interval (CI): 58.1 to 127.6; p<0.001], favoring the intervention group. HRQoL also improved significantly, with a mean between-group difference in SGRQ score of -38.2 (95% CI: -46.7 to -29.8; p<0.001). These findings indicate that initiating structured self-management during hospitalization for acute exacerbation of COPD results in significant improvements in inhaler adherence, functional capacity, and quality of life. Integrating self-management into acute care pathways may therefore optimize patient-centered outcomes in this high-risk population.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148563556","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"From benign airway lesions to bioengineered solutions: 3D bioprinting in tracheobronchopathia osteochondroplastica.","authors":"Haris Hanif","doi":"10.4081/monaldi.2026.3846","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3846","url":null,"abstract":"<p><p>Tracheobronchopathia osteochondroplastica is a rare benign lesion of the airways often managed conservatively. However, advanced obstruction requires reconstruction. This brief commentary explores the emerging role of 3D bioprinting as a curative solution, analyzing recent findings regarding mesenchymal stem cell-laden grafts and identifying vascularization as the critical hurdle preventing clinical translation.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148551372","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Vincenzo Zagà, Abdullah Al-Suhaim, Lojain Khoj, Alberto Fantin, Matthew J Cecchini, Maurizio Zompatori, Marco Mura
{"title":"Amiodarone-induced pulmonary toxicity: case series and review of clinical-radiological correlations.","authors":"Vincenzo Zagà, Abdullah Al-Suhaim, Lojain Khoj, Alberto Fantin, Matthew J Cecchini, Maurizio Zompatori, Marco Mura","doi":"10.4081/monaldi.2026.3936","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3936","url":null,"abstract":"<p><p>Amiodarone is an effective and commonly used anti-arrhythmic drug. The radiographic presentations of amiodarone-induced pulmonary toxicity (AIPT) include a broad spectrum of patterns. Three main clinical-radiographic presentations are described with AIPT: isolated reduction of diffusing lung capacity with no clinical implications; alveolar-interstitial pneumonia, which usually requires amiodarone discontinuation and corticosteroid treatment; and acute respiratory distress syndrome, which can obviously be life-threatening. We report 6 cases that depict the described range of clinical and radiographic presentations. The analysis of the cases and of the published review suggests that the computed tomography scan pattern on presentation predicts well the clinical course. The correlation between radiographic and clinical findings can therefore guide the clinician in the management of AIPT.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148474180","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Corticosteroids in severe pediatric community-acquired pneumonia:insights from a case-based narrative review.","authors":"Daniela Milanova-Ilieva, Atilla Genc, Kostadin Ketev","doi":"10.4081/monaldi.2026.3883","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3883","url":null,"abstract":"<p><p>Pediatric community-acquired pneumonia (CAP) remains a leading cause of hospitalization worldwide. Although antimicrobial therapy is the cornerstone of treatment, severe and complicated cases are frequently characterized by an exaggerated inflammatory response that may not resolve with antibiotics alone. In this narrative review, we summarize current evidence on the use of systemic corticosteroids as adjunctive therapy in pediatric CAP and illustrate their potential role through a representative clinical case. Available data from randomized trials, observational studies, and meta-analyses suggest that corticosteroids may shorten fever duration, improve oxygenation, and reduce length of hospital stay in selected pediatric patients, particularly those with hyperinflammatory features, parapneumonic effusions, or macrolide-refractory Mycoplasma pneumoniae infections. Some studies also indicate a reduced need for surgical intervention in complicated pneumonia. However, results remain heterogeneous, and current guidelines do not support routine corticosteroid use. Adverse effects are generally mild with short treatment courses and include hyperglycemia and transient behavioral changes. In the presented clinical case, adjunctive corticosteroid therapy was associated with rapid clinical and radiological improvement in a child with severe hyperinflammatory pleuropneumonia. Corticosteroids may represent a potential adjunctive option in carefully selected children with severe or complicated CAP; however, current evidence remains limited and heterogeneous, and further prospective pediatric studies are required.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148474218","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Balancing control and safety: hypothalamic-pituitary-adrenal axis effects of dual-route fluticasone in unified airway disease.","authors":"Ramakant Dixit, Mukesh Goyal","doi":"10.4081/monaldi.2026.3521","DOIUrl":"https://doi.org/10.4081/monaldi.2026.3521","url":null,"abstract":"<p><p>The concurrent presence of allergic rhinitis and bronchial asthma, known as unified airway disease, often requires combined therapeutic approaches. This prospective study investigates the clinical efficacy and safety of combined inhaled and intranasal fluticasone propionate in such patients. A total of 25 adult patients with moderate to severe allergic rhinitis and bronchial asthma were enrolled. After excluding 2 lost-to-follow-up patients, 23 patients completed the study. Participants received combined inhaled and intranasal fluticasone propionate for four weeks. Clinical outcomes were assessed using Total Nasal Symptom Score (TNSS), Asthma Control Test (ACT), spirometry, and 24-hour urinary free cortisol levels pre- and post-treatment. Significant improvements were observed in TNSS (9.09±2.89 to 2.13±1.62; p<0.0001) and ACT scores (20.48±3.07 to 24.09±1.12; p<0.0001). Pulmonary function tests showed significant increases in forced vital capacity from 3.16±0.73 L to 3.75±0.63 L (p=0.0053) and forced expiratory volume in 1 second from 2.18±0.75 L to 2.71±0.80 L (p=0.0252). Mean urinary free cortisol levels decreased from 31.35±9.35 mcg/24 h to 28.02±9.14 mcg/24 h, though the change was not statistically significant (p=0.2295). Combined inhaled and intranasal fluticasone propionate therapy significantly improves symptom control and pulmonary function in patients with allergic rhinitis and bronchial asthma. No significant suppression of the hypothalamic-pituitary-adrenal axis was observed, indicating a favorable safety profile for short-term use.</p>","PeriodicalId":51593,"journal":{"name":"Monaldi Archives for Chest Disease","volume":" ","pages":""},"PeriodicalIF":0.8,"publicationDate":"2026-07-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148426010","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}